文献速递肝病消化内镜

瞬时弹性成像肝硬度检测用于识别门脉高压相关门窦血管性肝病

Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension.
PubMed 文献 · Hepatology · 2021-06-11

本研究为回顾性多中心研究,比较符合Vascular Liver Disease Interest Group标准的PSVD患者与活检证实的代偿期肝硬化(酒精、HCV或NAFLD相关)患者的TE-LSM。结果发现PSVD患者肝硬度中位数(7.9 kPa)显著低于各病因肝硬化(33.8、18.2、33.6 kPa,P<0.001)。以10 kPa为界值诊断PSVD特异度97%、阳性预测值85%;以20 kPa为界值排除PSVD敏感度94%、阴性预测值97%。

要点

  • 有门脉高压征象者TE-LSM<10 kPa强烈提示PSVD。
  • TE-LSM>20 kPa时PSVD可能性极低。
  • PSVD肝硬度中位数7.9 kPa,显著低于酒精、HCV及NAFLD相关肝硬化。

核心结论

  • 在具有门脉高压征象的患者中,TE-LSM<10 kPa强烈提示PSVD,而TE-LSM>20 kPa时PSVD可能性极低。

研究设计与样本

  • 回顾性多中心研究,比较符合Vascular Liver Disease Interest Group标准的PSVD患者与活检证实的代偿期肝硬化患者(酒精n=117、HCV n=110、NAFLD n=46)的TE-LSM。
  • 测试队列纳入77例PSVD患者,验证队列纳入78例PSVD患者,共155例PSVD和273例肝硬化患者。
  • 所有患者至少具备一项门脉高压征象:胃食管静脉曲张、脾肿大、门体侧支循环、腹水史或血小板计数<150×10^9/L。

主要发现

  • PSVD患者TE-LSM中位数7.9 kPa,酒精相关肝硬化33.8 kPa、HCV相关肝硬化18.2 kPa、NAFLD相关肝硬化33.6 kPa(P<0.001)。
  • 与肝硬化相比,TE-LSM cutoff值10 kPa诊断PSVD特异度97%、阳性预测值85%。
  • TE-LSM cutoff值20 kPa排除PSVD敏感度94%、阴性预测值97%。
  • 94%的患者被正确分类,验证队列结果更优。

关键数值与推荐

  • TE-LSM<10 kPa:诊断PSVD特异度97%,阳性预测值85%。
  • TE-LSM>20 kPa:排除PSVD敏感度94%,阴性预测值97%。
  • PSVD患者TE-LSM中位数7.9 kPa,酒精相关肝硬化33.8 kPa、HCV相关肝硬化18.2 kPa、NAFLD相关肝硬化33.6 kPa(P<0.001)。

临床怎么用

  • 对具有门脉高压征象但病因不明确者,可用TE-LSM辅助鉴别PSVD与肝硬化。
  • TE-LSM<10 kPa时应考虑PSVD而非肝硬化,避免误诊。
  • TE-LSM>20 kPa时PSVD可能性低,可基本排除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Porto-sinusoidal vascular liver disease (PSVD) is a rare cause of portal hypertension. PSVD is still often misdiagnosed as cirrhosis, emphasizing the need to improve PSVD diagnosis strategies. Data on liver stiffness measurement using transient elastography (TE-LSM) in PSVD are limited. The aim of this study was to evaluate the accuracy of TE-LSM to discriminate PSVD from cirrhosis in patients with signs of portal hypertension. APPROACH AND RESULTS: Retrospective multicenter study comparing TE-LSM in patients with PSVD, according to Vascular Liver Disease Interest Group criteria, with patients with compensated biopsy-proven cirrhosis associated with alcohol (n = 117), HCV infection (n = 110), or NAFLD (n = 46). All patients had at least one sign of portal hypertension among gastroesophageal varices, splenomegaly, portosystemic collaterals, history of ascites, or platelet count < 150 × 109 /L. The 77 patients with PSVD included in the test cohort had lower median TE-LSM (7.9 kPa) than the patients with alcohol-associated, HCV-related, and NAFLD-related cirrhosis (33.8, 18.2, and 33.6 kPa, respectively; P < 0.001). When compared with cirrhosis, a cutoff value of 10 kPa had a specificity of 97% for the diagnosis of PSVD with a 85% positive predictive value. A cutoff value of 20 kPa had a sensitivity of 94% for ruling out PSVD with a 97% negative predictive value. Of the patients, 94% were well-classified. Even better results were obtained in a validation cohort including 78 patients with PSVD. CONCLUSIONS: This study including a total of 155 patients with PSVD and 273 patients with cirrhosis demonstrates that TE-LSM < 10 kPa strongly suggests PSVD in patients with signs of portal hypertension. Conversely, when TE-LSM is >20 kPa, PSVD is highly unlikely.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Elkrief L, Lazareth M, Chevret S, et al. Liver Stiffness by Transient Elastography to Detect Porto-Sinusoidal Vascular Liver Disease With Portal Hypertension. Hepatology. 2021. PMID: 33345307. doi:10.1002/hep.31688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。